Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Introduction Chronic Liver Disease continues to rise globally, driven predominantly by Metabolic Dysfunction-Associated Steatotic Liver Disease and alcohol-associated liver disease. Accurate evaluation of fibrosis severity and hepatic functional...
Introduction Metabolic Dysfunction-Associated Steatotic Liver Disease is increasingly recognized as a systemic disorder extending beyond hepatic steatosis and fibrosis. Cardiovascular disease remains the leading cause of mortality in...
Introduction Metabolic Dysfunction-Associated Steatotic Liver Disease is increasingly recognized as a major driver of progressive liver fibrosis, cirrhosis and liver-related mortality worldwide. Although obesity, insulin resistance and diabetes...
Introduction Obesity is increasingly recognized as a chronic, relapsing, multisystem disease requiring long-term, complication-oriented management rather than a purely weight-centric approach. The rapid expansion of anti-obesity pharmacotherapy, particularly...
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) have emerged as dominant causes of chronic liver disease worldwide, paralleling the epidemics of obesity and...
Introduction Wine has historically been investigated for its cardioprotective effects, particularly in the context of the “French paradox,” but emerging evidence suggests that moderate wine consumption may exert...
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is now one of the most common chronic liver diseases worldwide, affecting nearly one in four adults. Although much of the...
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the leading cause of chronic liver disease worldwide and closely parallels the epidemics of obesity and type 2 diabetes....
Introduction Metabolically–dysfunction–associated steatotic liver disease (MASLD) is a complex and heterogeneous condition where fibrosis plays a central role in disease progression and hepatocellular carcinoma (HCC) risk. Traditional histological...
Introduction Metabolic dysfunction–associated steatotic liver disease (MASLD) has traditionally been linked with obesity and metabolic syndrome. However, an emerging subset—lean MASLD—is increasingly recognised, particularly in Asian populations. Despite...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.